1. Home
  2. NKTR vs AVD Comparison

NKTR vs AVD Comparison

Compare NKTR & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • AVD
  • Stock Information
  • Founded
  • NKTR 1990
  • AVD 1969
  • Country
  • NKTR United States
  • AVD United States
  • Employees
  • NKTR N/A
  • AVD N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • AVD Agricultural Chemicals
  • Sector
  • NKTR Health Care
  • AVD Industrials
  • Exchange
  • NKTR Nasdaq
  • AVD Nasdaq
  • Market Cap
  • NKTR 160.4M
  • AVD 135.6M
  • IPO Year
  • NKTR 1994
  • AVD N/A
  • Fundamental
  • Price
  • NKTR $0.74
  • AVD $4.43
  • Analyst Decision
  • NKTR Strong Buy
  • AVD Strong Buy
  • Analyst Count
  • NKTR 5
  • AVD 2
  • Target Price
  • NKTR $5.50
  • AVD $17.00
  • AVG Volume (30 Days)
  • NKTR 1.4M
  • AVD 271.4K
  • Earning Date
  • NKTR 03-12-2025
  • AVD 03-14-2025
  • Dividend Yield
  • NKTR N/A
  • AVD 0.68%
  • EPS Growth
  • NKTR N/A
  • AVD N/A
  • EPS
  • NKTR N/A
  • AVD N/A
  • Revenue
  • NKTR $98,427,000.00
  • AVD $553,839,000.00
  • Revenue This Year
  • NKTR N/A
  • AVD N/A
  • Revenue Next Year
  • NKTR N/A
  • AVD $5.98
  • P/E Ratio
  • NKTR N/A
  • AVD N/A
  • Revenue Growth
  • NKTR 9.21
  • AVD N/A
  • 52 Week Low
  • NKTR $0.65
  • AVD $4.20
  • 52 Week High
  • NKTR $1.93
  • AVD $13.13
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 36.32
  • AVD 42.05
  • Support Level
  • NKTR $0.84
  • AVD $4.20
  • Resistance Level
  • NKTR $0.92
  • AVD $4.74
  • Average True Range (ATR)
  • NKTR 0.08
  • AVD 0.28
  • MACD
  • NKTR -0.01
  • AVD 0.00
  • Stochastic Oscillator
  • NKTR 0.40
  • AVD 27.38

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: